Evidence for differential modulation of conditioned aversion and fear-conditioned analgesia by CB1 receptors

European Journal of Neuroscience

Volumn 20, Issue 3, 2004, Pages 848-852

  Finn, D P ^a   Beckett, S R G ^a   Richardson, D ^a   Kendall, D A ^a   Marsden, C A ^a   Chapman, V ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Cannabinoid; Formalin; Pain; Rat; SR141716A

Indexed keywords

CANNABINOID 1 RECEPTOR; FORMALDEHYDE; RIMONABANT;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVERSION; CONTROLLED STUDY; DEFECATION; DRUG EFFECT; FEAR; FREEZING TOLERANCE; LOCOMOTION; MALE; MODULATION; NOCICEPTION; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; RAT; SHOCK;

ANALGESIA; ANALYSIS OF VARIANCE; ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; CONDITIONING (PSYCHOLOGY); FEAR; MALE; MOTOR ACTIVITY; PAIN MEASUREMENT; PIPERIDINES; PYRAZOLES; RATS; RECEPTOR, CANNABINOID, CB1; TIME FACTORS;

EID: 3843083058     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2004.03509.x     Document Type: Article

References (30)

1. Bolles, R.C. & Fanselow, M.S. (1980) A perceptual-defensive- recuperative model of fear and pain. Behav. Brain Sci., 3, 291-301.
2. Calcagnetti, D.J., Helmstetter, F.J. & Fanselow, M.S. (1987) Quaternary naltrexone reveals the central mediation of conditional opioid analgesia. Pharmacol. Biochem. Behav., 27, 529-531.
3. del Carmen Garcia, M., Adler-Graschinsky, E. & Celuch, S.M. (2003) Hypotensive effect of anandamide through the activation of CB1 and VR1 spinal receptors in urethane-anesthetized rats. Naunyn Schmiedebergs Arch. Pharmacol., 368, 270-276.
4. Cichewicz, D.L. & McCarthy, E.A. (2003) Antinociceptive synergy between delta (9)-tetrahydrocannabinol and opioids after oral administration. J. Pharmacol. Exp. Ther., 304, 1010-1015.
5. De Petrocellis, L., Bisogno, T., Maccarrone, M., Davis, J.B., Finazzi-Agro, A. & Di Marzo, V. (2001) The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism. J. Biol. Chem., 276, 12856-12863.
6. Di Marzo, V., Lastres-Becker, I., Bisogno, T., De Petrocellis, L., Milone, A., Davis, J.B. & Fernandez-Ruiz, J.J. (2001) Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues. Eur. J. Pharmacol., 420, 123-131.
7. Fanselow, M.S., Calcagnetti, D.J. & Helmstetter, F.J. (1989) Role of mu and kappa opioid receptors in conditional fear-induced analgesia: the antagonistic actions of nor-binaltorphimine and the cyclic somatostatin octapeptide, Cys2Tyr3Orn5Pen7-amide. J. Pharmacol. Exp. Ther., 250, 825-830.
8. Fanselow, M.S. & Helmstetter, F.J. (1988) Conditional analgesia, defensive freezing, and benzodiazepines. Behav. Neurosci., 102, 233-243.
9. Finn, D.P., Beckett, S.R.G., Roe, C.H., Madjd, A., Fone, K.C.F., Kendall, D.A., Marsden, C.A. & Chapman, V. (2004a) Effects of co-administration of cannabinoids and opioids on nociceptive behaviour, brain monoamines and HPA axis activity in a rat model of persistent pain. Eur. J. Neurosci., 19, 678-686.
10. Finn, D.P. & Chapman, V. (2004) Cannabinoids as analgesic agents: evidence from in vivo studies. Curr. Neuropharmacol., 2, 75-89.
11. Finn, D.P., Chapman, V., Jhaveri, M.D., Samanta, S., Manders, T., Bowden, J., Matthews, L., Marsden, C.A. & Beckett, S.R.G. (2003b) The role of the central nucleus of the amygdala in nociception and aversion. Neuroreport, 14, 981-984.
12. Finn, D.P., Jhaveri, M.D., Beckett, S.R.G., Kendall, D.A., Marsden, C.A. & Chapman, V. (2004b) Cannabinoids modulate ultrasound-induced aversive responses in rats. Psychopharmacology (Berl.), 172, 41-51.
13. Finn, D.P., Jhaveri, M.D., Beckett, S.R., Roe, C.H., Kendall, D.A., Marsden, C.A. & Chapman, V. (2003a) Effects of direct periaqueductal grey administration of a cannabinoid receptor agonist on nociceptive and aversive responses in rats. Neuropharmacology, 45, 594-604.
14. Harris, J.A. & Westbrook, R.F. (1994) Effects of midazolam and naloxone in rats tested for sensitivity/reactivity to formalin pain in a familiar, novel or aversively conditioned environment. Psychopharmacology (Berl.), 115, 65-72.
15. Harris, J.A. & Westbrook, R.F. (1995) Effects of benzodiazepine microinjection into the amygdala or periaqueductal gray on the expression of conditioned fear and hypoalgesia in rats. Behav. Neurosci., 109, 295-304.
16. Helmstetter, F.J. (1992) The amygdala is essential for the expression of conditional hypoalgesia. Behav. Neurosci., 106, 518-528.
17. Herkenham, M., Lynn, A.B., Johnson, M.R., Melvin, L.S., de Costa, B.R. & Rice, K.C. (1991) Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci., 11, 563-583.
18. Hillard, C.J., Manna, S., Greenberg, M.J., DiCamelli, R., Ross, R.A., Stevenson, L.A., Murphy, V., Pertwee, R.G. & Campbell, W.B. (1999) Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1). J. Pharmacol. Exp. Ther., 289, 1427-1433.
19. Izzo, A.A., Mascolo, N., Borrelli, F. & Capasso, F. (1999) Defaecation, intestinal fluid accumulation and motility in rodents: implications of cannabinoid CB1 receptors. Naunyn Schmiedebergs Arch. Pharmacol., 359, 65-70.
20. Jarbe, T.U., Andrzejewski, M.E. & DiPatrizio, N.V. (2002) Interactions between the CB1 receptor agonist Delta 9-THC and the CB1 receptor antagonist SR-141716 in rats: open-field revisited. Pharmacol. Biochem. Behav., 73, 911-919.
21. Jia, Y., McLeod, R.L., Wang, X., Parra, L.E., Egan, R.W. & Hey, J.A. (2002) Anandamide induces cough in conscious guinea-pigs through VR1 receptors. Br. J. Pharmacol., 137, 831-836.
22. Kinscheck, I.B., Watkins, L.R. & Mayer, D.J. (1984) Fear is not critical to classically conditioned analgesia: the effects of periaqueductal gray lesions and administration of chlordiazepoxide. Brain Res., 298, 33-44.
23. Manning, B.H., Martin, W.J. & Meng, I.D. (2003) The rodent amygdala contributes to the production of cannabinoid-induced antinociception. Neuroscience, 120, 1157-1170.
24. Marsicano, G., Wotjak, C.T., Azad, S.C., Bisogno, T., Rammes, G., Cascio, M.G., Hermann, H., Tang, J., Hofmann, C., Zieglgansberger, W., Di Marzo, V. & Lutz, B. (2002) The endogenous cannabinoid system controls extinction of aversive memories. Nature, 418, 530-534.
25. Meng, I.D., Manning, B.H., Martin, W.J. & Fields, H.L. (1998) An analgesia circuit activated by cannabinoids. Nature, 395, 381-383.
26. Meschler, J.P., Kraichely, D.M., Wilken, G.H. & Howlett, A.C. (2000) Inverse agonist properties of N-(piperidin-1-yl) -5-(4-chlorophenyl) -1-(2, 4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide HCl (SR141716A) and 1-(2-chlorophenyl)-4-cyano-5-(4-methoxyphenyl)-1H-pyrazole-3-carboxylic acid phenylamide (CP-272871) for the CB (1) cannabinoid receptor. Biochem. Pharmacol., 60, 1315-1323.
27. Palazzo, E., de Novellis, V., Marabese, I., Cuomo, D., Rossi, F., Berrino, L. & Maione, S. (2002) Interaction between vanilloid and glutamate receptors in the central modulation of nociception. Eur. J. Pharmacol., 439, 69-75.
28. Strangman, N.M., Patrick, S.L., Hohmann, A.G., Tsou, K. & Walker, J.M. (1998) Evidence for a role of endogenous cannabinoids in the modulation of acute and tonic pain sensitivity. Brain Res., 813, 323-328.
29. Watson, G.S., Sufka, K.J. & Coderre, T.J. (1997) Optimal scoring strategies and weights for the formalin test in rats. Pain, 70, 53-58.
30. Welch, S.P. & Eads, M. (1999) Synergistic interactions of endogenous opioids and cannabinoid systems. Brain Res., 848, 183-190.